Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer
Ace Vision Group announced that it has named Val Kolesnitchenko, MD, as Chief Scientific Officer.
Dr. Kolesnitchenko has served in leadership roles for three decades in clinical ophthalmology practice and industry. Most recently, he held the position of Executive Director of Global Scientific Affairs at Bausch + Lomb, overseeing the medical and clinical development of the company’s surgical portfolio.
Explore More Articles
THE ZOOMING EYE LENS: Effects of Age on Dynamic Range of Focus
DYNAMIC RANGE OF FOCUS (DRoF), or the total range of clear vision in a natural system, is an important biomechanical function of the accommodative apparatus responsible for adjusting the crystalline lens from both far to near (accommodation) and near to far (disaccommodation). DRoF is defined by true accommodation, pseudoaccommodation, and pupillary diaphragmatic changes, which work together …
read moreLaser scleral microporation may solve biomechanical problem of presbyopia
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Lopez of Ace Vision Group discusses laser scleral microporation for presbyopia. Lopez said the GenII device can potentially deliver improved near vision without compromising distance vision in patients with presbyopia. The company plans to do a study in the United States in 2026, potentially leading to commercial availability in …
read morePresbyopia treatment options now and on the horizon
The large number of patients worldwide with presbyopia creates a unique opportunity for eyecare providers to improve patients’ quality of life, according to George Waring IV, MD, FACS. There are more than 2.1 billion presbyopes worldwide. Dr. Waring noted the many implications of this large number, not just from a quality of life standpoint but …
read more